0001755010-22-000001.txt : 20221014 0001755010-22-000001.hdr.sgml : 20221014 20221014120740 ACCESSION NUMBER: 0001755010-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221014 DATE AS OF CHANGE: 20221014 EFFECTIVENESS DATE: 20221014 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EPALEX Corp CENTRAL INDEX KEY: 0001755010 IRS NUMBER: 273424771 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-461755 FILM NUMBER: 221310692 BUSINESS ADDRESS: STREET 1: 1049 EL MONTE AVENUE, SUITE C 585 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94040 BUSINESS PHONE: 659-946-3366 X700 MAIL ADDRESS: STREET 1: 1049 EL MONTE AVENUE, SUITE C 585 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94040 D 1 primary_doc.xml X0708 D LIVE 0001755010 EPALEX Corp 1049 EL MONTE AVENUE, SUITE C 585 MOUNTAIN VIEW CA CALIFORNIA 94040 659-946-3366 X700 DELAWARE None None Corporation true Brendan Magrab c/o Epalex Corporation 1049 El Monte Avenue, Suite C 585 Mountain View CA CALIFORNIA 94040 Executive Officer Director Randall Murphy c/o Epalex Corporation 1049 El Monte Avenue, Suite C 585 Mountain View CA CALIFORNIA 94040 Director Michael Rogawski c/o Epalex Corporation 1049 El Monte Avenue, Suite C 585 Mountain View CA CALIFORNIA 94040 Director Jon S. Saxe c/o Epalex Corporation 1049 El Monte Avenue, Suite C 585 Mountain View CA CALIFORNIA 94040 Director Matthew Smith c/o Epalex Corporation 1049 El Monte Avenue, Suite C 585 Mountain View CA CALIFORNIA 94040 Director Pharmaceuticals Decline to Disclose 06b false 2022-10-04 false true false 0 8499980 4260617 4239363 false 15 0 0 650000 Estimated total cash compensation in respect of fiscal year ending December 31, 2022. false EPALEX Corp /s/ Brendan Magrab Brendan Magrab President and Chief Executive Officer 2022-10-11